ACTRN12612000512820进行中(未招募)未知
A pilot safety and acceptability trial of moderated on-line social therapy (MOST) for first-episode psychosis.
Helen Macpherson Smith Trust0 个研究点目标入组 20 人开始时间: 2012年5月14日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 进行中(未招募)
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 15 Years 至 25 Years(—)
- 性别
- All
入选标准
- •(a) a first episode of a DSM-IV psychotic disorder or mood disorder with psychotic features; (b) aged 15-25 years inclusive; (c) less than or equal to 6 months treatment with an antipsychotic medication prior to registration with the early psychosis service; (d) remission on positive symptoms of psychosis which will be defined as 4 weeks or more of scores of 3 (mild) or below on the subscale items hallucinations, unusual thought disorder, conceptual disorganization, and suspiciousness on the expanded version of the Brief Psychiatric Rating Scale (BPRS). Additional inclusion criteria to ensure low level of risk within MOST include: (e) low aggressiveness which will be defined by a score of 5 or below (with the exception of evidence of threat to others) on the hostility subscale of the expanded version of the BPRS for the month prior to study entry; and, (f) low suicidal risk defined as a score of 4 or below on the suicidality subscale for the month preceding study entry.
排除标准
- •(a) intellectual disability; (b) inability to converse in, or read English; (c) participation in previous CBT or pharmacological trials for psychosis; (d) a DSM-IV diagnosis of either antisocial personality disorder (ASPD) or borderline personality disorder (BPD); (e) pregnancy; (f) medical conditions requiring high level of care; (g) presence of acute psychotic symptoms above a mild level; (h) presence of moderate or above levels of suicidality or hostility.
研究者
相似试验
进行中(未招募)
1 期
A study to assess safety and acceptability of a treatment in patients with ALSMotor Neurone Disease (MND)/Amyotrophic Lateral Sclerosis (ALS)MedDRA version: 20.0 Level: PT Classification code 10002026 Term: Amyotrophic lateral sclerosis System Organ Class: 10029205 - Nervous system disordersEUCTR2018-000668-28-GBniversity of Birmingham15
已完成
2 期
AYUSH 64 for accelerating the recovery in cases of InfluenzaCTRI/2017/10/010145Central Council for Research in Ayurvedic Sciences Ministry of AYUSH GoI
终止
1 期
A pilot study of Lewis-Y targeting Chimeric Antigen Receptor T-cells given in combination with Nivolumab in Lewis-Y expressing solid tumours.ACTRN12622001542785Peter MacCallum Cancer Centre4
招募中
不适用
A safety and efficacy pilot study on the use of a continuous distraction spring in addition to growing rod surgery in children with congenital, neuromuscular or idiopathic spinal deformities.ScolioseSpinal growth deformitiesscoliosisNL-OMON56121niversitair Medisch Centrum Utrecht160
已完成
不适用
A safety and exploratory efficacy pilot study of Needlecalm™ in reducing pain and needle sensation in a venepuncture procedure: a single group, single-blinded, randomised placebo-controlled investigation in healthy volunteers.ACTRN12618001645246eedlecalm Pty Ltd12
